GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinco Pharmaceutical Holdings Ltd (HKSE:06833) » Definitions » Price-to-Tangible-Book

Sinco Pharmaceutical Holdings (HKSE:06833) Price-to-Tangible-Book : 0.64 (As of Dec. 14, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Sinco Pharmaceutical Holdings Price-to-Tangible-Book?

As of today (2024-12-14), Sinco Pharmaceutical Holdings's share price is HK$0.185. Sinco Pharmaceutical Holdings's Tangible Book per Share of Jun. 2024 for the quarter that ended in Jun. 2024 was HK$0.29. Hence, Sinco Pharmaceutical Holdings's Price to Tangible Book Ratio of today is 0.64.

The historical rank and industry rank for Sinco Pharmaceutical Holdings's Price-to-Tangible-Book or its related term are showing as below:

HKSE:06833' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.63   Med: 2.59   Max: 23.13
Current: 0.64

During the past 10 years, Sinco Pharmaceutical Holdings's highest Price to Tangible Book Ratio was 23.13. The lowest was 0.63. And the median was 2.59.

HKSE:06833's Price-to-Tangible-Book is ranked better than
87.64% of 89 companies
in the Medical Distribution industry
Industry Median: 1.31 vs HKSE:06833: 0.64

A closely related ratio is called PB Ratio. As of today, Sinco Pharmaceutical Holdings's share price is HK$0.185. Sinco Pharmaceutical Holdings's Book Value per Sharefor the quarter that ended in Jun. 2024 was HK$0.34. Hence, Sinco Pharmaceutical Holdings's P/B Ratio of today is 0.54.


Sinco Pharmaceutical Holdings Price-to-Tangible-Book Historical Data

The historical data trend for Sinco Pharmaceutical Holdings's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinco Pharmaceutical Holdings Price-to-Tangible-Book Chart

Sinco Pharmaceutical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.77 2.54 7.71 0.92 0.83

Sinco Pharmaceutical Holdings Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.83 0.92 1.05 0.83 0.84

Competitive Comparison of Sinco Pharmaceutical Holdings's Price-to-Tangible-Book

For the Medical Distribution subindustry, Sinco Pharmaceutical Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinco Pharmaceutical Holdings's Price-to-Tangible-Book Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sinco Pharmaceutical Holdings's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Sinco Pharmaceutical Holdings's Price-to-Tangible-Book falls into.



Sinco Pharmaceutical Holdings Price-to-Tangible-Book Calculation

Sinco Pharmaceutical Holdings's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2024 )
=0.185/0.289
=0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Sinco Pharmaceutical Holdings Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Sinco Pharmaceutical Holdings's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinco Pharmaceutical Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 1700, North Section of Tianfu Avenue, E5-1805, Global Centre, High-Tech Zone, Chengdu, Sichuan Province, Chengdu, CHN
Sinco Pharmaceutical Holdings Ltd is an investment holding company that deals in marketing, promotion, and channel management of improved human plasma-based pharmaceuticals, antibiotics, and other pharmaceuticals. The company operates in three business segments, namely biologics, medical aesthetic products, and biopharmaceutical cold chain and supply chain services. The biologics business provides marketing, promotion, and channel management services, while the medical aesthetic products business focuses on research and development, production, and sales of aesthetic medicine in China. The biopharmaceutical cold chain and supply chain services concentrate on the construction of cold chain facilities for biopharmaceutical products and establishing the supply chain service platform.
Executives
Huang Zhijian 2305 Beneficiary of a trust
Fullwealth Holdings Limited 2201 Interest of corporation controlled by you
Risun Investments Limited 2101 Beneficial owner
Wickhams Cay Trust Company Limited 2301 Trustee
Huang Xiangbin 2307 Founder of a discretionary trust who can infl

Sinco Pharmaceutical Holdings Headlines

No Headlines